[{"indications": "Indications\u00a0see notes above and under preparations", "name": "DALTEPARIN SODIUM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.8 Anticoagulants and protamine", "2.8.1 Parenteral anticoagulants", "Low molecular weight heparins", "DALTEPARIN SODIUM"], "cautions": "Cautions\u00a0see under Heparin and notes above", "side-effects": "Side-effects\u00a0see under Heparin", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2774.htm", "doses": ["See under preparations below", "prophylaxis of deep-vein thrombosis, in surgical patients, by subcutaneous injection, moderate risk, 2500\u00a0units 1\u20132\r\nhours before surgery then 2500\u00a0units every 24 hours; high risk, 2500\u00a0units\r\n1\u20132 hours before surgery, then 2500\u00a0units 8\u201312 hours later (or 5000\u00a0units on the evening before surgery, then 5000\u00a0units\r\non the following evening), then 5000\u00a0units every 24 hours", "treatment of deep-vein thrombosis and of pulmonary embolism, by subcutaneous injection, 200\u00a0units/kg (max. 18\u00a0000\u00a0units)\r\nas a single daily dose (or 100\u00a0units/kg twice daily\r\nif increased risk of haemorrhage) until adequate oral anticoagulation\r\nestablished", "For monitoring, blood should\r\nbe taken 3\u20134 hours after a dose (recommended plasma concentration\r\nof anti-Factor Xa 0.5\u20131\u00a0unit/mL); monitoring not required for once-daily\r\ntreatment regimen and not generally necessary for twice-daily regimen", "unstable coronary artery disease (including non-ST-segment-elevation\r\nmyocardial infarction), by subcutaneous injection,\r\n120\u00a0units/kg every 12 hours (max. 10\u00a0000\u00a0units twice daily) for up\r\nto 8 days; beyond 8 days (if awaiting angiography or revascularisation)\r\nwomen body-weight less than 80\u00a0kg and men less than 70\u00a0kg, 5000 units\r\nevery 12 hours, women body-weight greater than 80\u00a0kg and men greater\r\nthan 70\u00a0kg, 7500\u00a0units every 12 hours, until day of procedure (max.\r\n45 days)"], "pregnancy": "Pregnancy\u00a0not known to be harmful; multidose vial contains\r\nbenzyl alcohol\u2014manufacturer advises avoid; see also Pregnancy"}]